Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000602892 | SCV000716727 | likely benign | not specified | 2017-03-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001497191 | SCV001701913 | likely benign | 3-Methylglutaconic aciduria type 3; Optic atrophy 3 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003962754 | SCV004783517 | likely benign | OPA3-related disorder | 2023-01-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |